CH677926A5 - - Google Patents

Download PDF

Info

Publication number
CH677926A5
CH677926A5 CH4687/88A CH468788A CH677926A5 CH 677926 A5 CH677926 A5 CH 677926A5 CH 4687/88 A CH4687/88 A CH 4687/88A CH 468788 A CH468788 A CH 468788A CH 677926 A5 CH677926 A5 CH 677926A5
Authority
CH
Switzerland
Prior art keywords
ciclosporin
iii
particle size
crystal form
practically
Prior art date
Application number
CH4687/88A
Other languages
German (de)
English (en)
Inventor
Danielle Dr Giron
Martin Dr List
Friedrich Dr Richter
Yasuyuki Uike
Hans Peter Dr Weber
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH677926A5 publication Critical patent/CH677926A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CH4687/88A 1987-12-21 1988-12-19 CH677926A5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13623087A 1987-12-21 1987-12-21
US17261388A 1988-03-24 1988-03-24
US21254888A 1988-06-28 1988-06-28

Publications (1)

Publication Number Publication Date
CH677926A5 true CH677926A5 (es) 1991-07-15

Family

ID=27384838

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4687/88A CH677926A5 (es) 1987-12-21 1988-12-19

Country Status (27)

Country Link
JP (1) JPH0791316B2 (es)
KR (1) KR100188305B1 (es)
AT (1) AT403163B (es)
AU (1) AU626274B2 (es)
BE (1) BE1002665A4 (es)
CA (1) CA1341396C (es)
CH (1) CH677926A5 (es)
CY (1) CY1799A (es)
DE (1) DE3843054C2 (es)
DK (1) DK175220B1 (es)
ES (1) ES2012580A6 (es)
FI (1) FI89065C (es)
FR (1) FR2624863B1 (es)
GB (1) GB2211848B (es)
GR (1) GR1002486B (es)
HK (1) HK102894A (es)
HU (1) HU203564B (es)
IE (1) IE62006B1 (es)
IL (1) IL88719A0 (es)
IT (1) IT1235356B (es)
LU (1) LU87409A1 (es)
MY (1) MY103943A (es)
NL (1) NL195096C (es)
NO (1) NO177228C (es)
NZ (1) NZ227384A (es)
SE (1) SE503174C2 (es)
SG (1) SG99494G (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
JP3631490B2 (ja) 1992-05-13 2005-03-23 ノバルティス ファーマ株式会社 シクロスポリン含有眼科用組成物
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
RU2158601C2 (ru) 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US6262054B1 (en) * 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
RU2211047C2 (ru) 1997-01-30 2003-08-27 Новартис Аг Желатиновые капсулы с твердым покрытием, включающие фармацевтические композиции, практически не содержащие масел
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
AU2005209201B2 (en) 2004-01-20 2010-06-03 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
CN1763084B (zh) * 2005-10-11 2010-04-21 山东新时代药业有限公司 高纯度环孢菌素a的制备方法
US8772245B2 (en) * 2011-05-27 2014-07-08 Allergan, Inc. Crystalline form of cyclosporine A, methods of preparation, and methods for use thereof
BR112014011768A2 (pt) * 2011-11-15 2017-05-09 Allergan Inc forma 2 de ciclosporina a e método de produção da mesma
AU2012339695B2 (en) 2011-11-15 2017-10-05 Allergan, Inc. Sustained action formulation of cyclosporin Form 2
KR102015151B1 (ko) 2011-11-15 2019-08-27 알러간, 인코포레이티드 사이클로스포린 a 제2형의 고압멸균처리 가능한 현탁액
WO2013074625A1 (en) * 2011-11-15 2013-05-23 Allergan, Inc. Suspensions of cyclosporin a form 2
WO2024085235A1 (ja) * 2022-10-20 2024-04-25 中外製薬株式会社 環状ペプチドの結晶の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (es) * 1975-11-04 1979-12-28 Sandoz Ag
CH640519A5 (en) * 1976-04-09 1984-01-13 Sandoz Ag Process for preparing a modified form of the antibiotic S 7481/F-1
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
CH637124A5 (en) * 1978-10-18 1983-07-15 Sandoz Ag Antibiotic, its preparation and use

Also Published As

Publication number Publication date
SG99494G (en) 1994-10-28
NZ227384A (en) 1991-09-25
HK102894A (en) 1994-09-30
DK705488A (da) 1989-06-22
IE62006B1 (en) 1994-12-14
SE8804570L (sv) 1989-06-22
FI89065C (fi) 1993-09-30
FI885869A (fi) 1989-06-22
IL88719A0 (en) 1989-07-31
KR100188305B1 (ko) 1999-06-01
DK175220B1 (da) 2004-07-12
SE8804570D0 (sv) 1988-12-19
JPH01211598A (ja) 1989-08-24
GB2211848A (en) 1989-07-12
IE883779L (en) 1989-06-21
AT403163B (de) 1997-11-25
AU626274B2 (en) 1992-07-30
NL8803125A (nl) 1989-07-17
AU2705588A (en) 1989-06-22
NO885625L (no) 1989-06-22
HU203564B (en) 1991-08-28
IT1235356B (it) 1992-06-30
FR2624863B1 (fr) 1991-04-26
DK705488D0 (da) 1988-12-19
NL195096C (nl) 2004-02-09
FI885869A0 (fi) 1988-12-19
GR1002486B (el) 1996-12-09
CY1799A (en) 1995-02-17
CA1341396C (en) 2002-11-05
GR880100850A (el) 1994-03-31
IT8848690A0 (it) 1988-12-20
NO177228B (no) 1995-05-02
ATA309588A (de) 1997-04-15
HUT49893A (en) 1989-11-28
DE3843054A1 (de) 1989-07-27
NO177228C (no) 1995-08-09
GB2211848B (en) 1991-11-06
LU87409A1 (fr) 1989-07-07
ES2012580A6 (es) 1990-04-01
BE1002665A4 (fr) 1991-04-30
GB8829556D0 (en) 1989-02-08
KR890009975A (ko) 1989-08-05
FR2624863A1 (fr) 1989-06-23
MY103943A (en) 1993-10-30
DE3843054C2 (de) 2003-08-21
SE503174C2 (sv) 1996-04-15
NO885625D0 (no) 1988-12-19
JPH0791316B2 (ja) 1995-10-04
FI89065B (fi) 1993-04-30

Similar Documents

Publication Publication Date Title
CH677926A5 (es)
AT403435B (de) Cyclosporin enthaltende pharmazeutische zusammensetzung
DE4003844B4 (de) Neue Cyclosporin enthaltende galenische Formulierungen
DE60027171T2 (de) Nanopartikelzusammensetzungen enthaltend amorphes cyclosporin und deren herstellungsverfahren und verwendungsverfahren
EP1073426B1 (de) Pharmazeutische ciclosporin-formulierung mit verbesserten biopharmazeutischen eigenschaften, erhöhter physikalischer qualität & stabilität sowie verfahren zur herstellung
DE69004372T2 (de) Verfahren zum Mikronisieren schwerlöslicher Arzneistoffe.
AT390372B (de) Verwendung von solarfiltern zur stabilisierung und verbesserung der hautvertraeglichkeit von benzoylperoxyd enthaltenden zubereitungen zur lokalen aknebehandlung
DE60120696T2 (de) Wasserverdünnte emulsion mit niedrigem emulgatorgehalt
DE3382587T2 (de) Injizierbares langwirkendes mikroteilchen-praeparat zur verabreichung entzuendungshemmender mittel.
DE69914742T2 (de) Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
EP1289502B1 (de) Mikroemulsion-prekonzentrat, mikroemulsion und verwendung einer zusammensetzung
DE60017296T2 (de) Stabile Emulsion,Verfahren zur Herstellung und Emulgiermittel
DE2757827A1 (de) Arzneipraeparate mit einem gehalt an einem isosorbid-loesungsmittelsystem
DE3713492C2 (es)
DE60018081T2 (de) Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung
CH683672A5 (de) Wasserlösliche Monoester als Solubilisatoren für pharmakologische Wirkstoffe und pharmazeutische Hilfsstoffe.
DE2902863A1 (de) Waessriges gel zur anwendung im bindehautsack
DE60100389T2 (de) Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung
DE3238800A1 (de) Mit (gamma)-cyclodextrin gebildete einschlusskomplexe von steroidverbindungen, verfahren zu ihrer herstellung und diese einschlusskomplexe enthaltende arzneimittelpraeparate
DE68914683T2 (de) Arzneimittelzusammensetzung für die schnelle verabreichung des aktiven bestandteils, der aus einer festen dispersion und einem oberflächenaktiven mittel besteht.
DE69122780T2 (de) Benzenedimethanolderivat geeignet für mikronisierung
DE69122229T2 (de) Penciclovir enthaltende pharmazeutische formulierung
DE69203071T2 (de) Verfahren zur erhoehung der therapeutischen wirksamkeit fettloeslicher fungizideaus der familie der imidazole sowie mittel zur durchfuehrung dieses verfahren.
EP1077676A2 (de) Cyclosporin-zubereitungen
DD283404A5 (de) Verfahren zur herstellung von ciclosporin in nichtsolvatisiertr orthonombischer kristallform

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: SANDOZ AG TRANSFER- NOVARTIS AG

PL Patent ceased